Navigation Links
ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS
Date:3/5/2010

ed moment," said R. Rodney Howell, M.D., Chairman of the MDA Board of Directors. "More than 30 people with familial ALS caused by mutations in the SOD1 gene soon will receive infusions of a SOD1 inhibitor directly into their central nervous systems."  Dr. Howell added that "MDA has invested more than $270 million fighting ALS, and it's exciting to see an excellent dose-escalation study get underway to assess the safety of ISIS-SOD1Rx."

ABOUT ISIS-SOD1Rx

ISIS-SOD1Rx is designed to inhibit the production of SOD1.  In preclinical studies, Isis, in collaboration with Timothy Miller, Don Cleveland (University of California, San Diego), and Richard Smith (Center for Neurological Study) were able to lower production of SOD1 with ISIS-SOD1Rx in neurons and surrounding cells and prolong life in rats that showed many symptoms of ALS.  In December 2007, the FDA granted ISIS-SOD1Rx Orphan Drug designation for the treatment of ALS. Because antisense drugs do not cross the blood-brain barrier, a small pump administers the drug directly into the central nervous system infusing the drug into the cerebral spinal fluid. Clinicians call this type of administration intrathecal infusion.  As part of Isis' alliance with Genzyme, Genzyme has a right of first negotiation to license ISIS-SOD1Rx from Isis.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Kinex Pharmaceuticals Initiates a Phase 2 Clinical Trial of KX2-391 in Patients with Prostate Cancer
2. QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission
3. Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Prevention of Recurrent Venous Thromboembolism
4. Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui
5. Romark Initiates Clinical Trial of Alinia for Treatment of Influenza
6. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
7. ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases
8. Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression
9. Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
10. ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis
11. Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015  Caris Life Sciences® today ... targeting specific pathways may have potentially significant benefit in ... study results were highlighted today in an oral presentation ... Oncology (SGO) 2015 Annual Meeting on Women,s Cancer in ... study is one of four presented at the annual ...
(Date:3/30/2015)... 2015 NiQ Health, "the ... the high level interface capabilities of their CarePlus™ ... The partnership between CarePlus™ and ClinicAll ... allows patients to choose the most appropriate alarm ... The advanced functionality of CarePlus™ allows patient alarms ...
(Date:3/30/2015)... Calif. , March 30, 2015 ... that it has initiated a multi-dose Phase 1 ... the lead molecule in DURECT,s Epigenomic Regulator Program.  ... (NCE) that may have broad applicability in metabolic ... and nonalcoholic steatohepatitis (NASH).  It may also play ...
Breaking Medicine Technology:Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 2Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 3Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 4NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4
... Neusoft Corporation ("Neusoft", 600718.SH), a leading IT solution ... its wholly-owned subsidiary Neusoft Europe Inc. ("Neusoft Europe") ... Systems Ltd. ("Aerotel"), a leading global manufacturer of ... solutions based in Israel, under which Neusoft Europe ...
... (NYSE: HSP ), a global specialty pharmaceutical and ... has authorized the repurchase of up to $1 billion of ... underscores our continued belief and optimism in Hospira,s long-term growth ... our shareholders," said F. Michael Ball, chief executive officer. "The ...
Cached Medicine Technology:Neusoft to Invest in Israeli Medical Solutions Company for Accelerating Expansion in Global Healthcare Service Market 2Hospira Board Authorizes $1 Billion Share Repurchase Program 2
(Date:3/31/2015)... Pass, OR (PRWEB) March 31, 2015 ... enthusiasts, late May to mid-June are anxiously awaited. After ... elevation treks, that’s when the winter snowpack in the ... and backers enthusiasts to access the high trails. The ... radio host Sharon Kleyne, was very different. For the ...
(Date:3/31/2015)... March 31, 2015 According to data ... start their own businesses fail within the first 18 ... up to change those numbers for the better. ... based out of the Mahoning Valley in Ohio. YBI ... by offering clients guidance on topics such as management ...
(Date:3/31/2015)... NYC based chiropractor Dr. Steven Shoshany, recently ... is proud to offer an improved and expanded use of ... able to offer percussive soft tissue treatment for ... able to offer full body Active Release Technique treatment and ... he is now also able to offer percussive therapy for ...
(Date:3/31/2015)... Jacksonville, FL (PRWEB) March 31, 2015 ... now see Drivable Grass in action and ... just finished installation of a display plot of ... Street. , Drivable Grass is a permeable concrete ... stylish alternative to asphalt and concrete pavement, Drivable Grass ...
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 ... independent freestanding emergency rooms in the United States, announced ... April. , “I am pleased to announce that ... Worth metroplex in Haslet,” said Dr. James M. Muzzarelli, ... , First Choice Emergency Room is revolutionizing the delivery ...
Breaking Medicine News(10 mins):Health News:2014-15 winter drought offers unique opportunity for Oregon and California hikers and backpackers reports fresh water advocate 2Health News:2014-15 winter drought offers unique opportunity for Oregon and California hikers and backpackers reports fresh water advocate 3Health News:Giving a Leg Up to the Start-ups: PeopleKeys Partners with Youngstown Business Incubator to Provide Support Services to Start-up Companies 2Health News:Giving a Leg Up to the Start-ups: PeopleKeys Partners with Youngstown Business Incubator to Provide Support Services to Start-up Companies 3Health News:NYC Chiropractor Dr Steven Shoshany Expands Percussive Massage Offering 2Health News:NYC Chiropractor Dr Steven Shoshany Expands Percussive Massage Offering 3Health News:Super-Sod Recently Completed a Drivable Grass Permeable Paver Demo at their Jacksonville Store 2Health News:First Choice Emergency Room to Open New Facility in Haslet, Texas 2
... Fries are out of the pan into the fire itself, ... recently enforced Government directives to disclose levels of trans fats ... test levels of trans fat in french fries.// The tests ... contain one third more ( 8 grammes as against earlier ...
... has been reported from a chicken farm located in the ... monitored and is believed to be under control, according to ... 15, 000 chickens in a farm (Yijing township), confirmed to ... to the above situation, a special team to combat spread ...
... The largest ever high blood pressure clinical trial is ... of controlling high blood pressure. // This is a ... Heart Attack Trial (ALLHAT) and is being launched in ... (NHBPEP). ,The ALLHAT blood pressure study ...
... Heart Disease (IHD) which is also called the Coronary Artery ... upon whether it is a man or woman. The blood ... and where Western countries are concerned, this is quite a ... for chest pain, diagnosticians typically look for an obstructive lesion ...
... to Kenya by the World Bank for HIV/AIDS education and ... it has been delayed due to some allegations pertaining to ... against the Kenyan government, the SAPA/Mail & Guardian reports (SAPA/Mail ... of Health in February 2005 it had failed to distribute ...
... of the Journal of Periodontology, says that chronic periodontal ... pregnancy. // The results of the study also indicate ... compared to women who do not have preeclampsia. ... the preeclamptic group by almost 64 percent than the ...
Cached Medicine News:Health News:Diuretics More Effective In Controlling High Blood Pressure 2Health News:Gum Disease Associated With Increased Risk of Preeclampsia 2
... Mandibular Immobilizer) A completely adjustable cervical ... hypertension positioning and immobilization. Offers a ... collar and a halo-type brace.,Mandibular and ... chin plate allows for patient eating ...
... Wrap® Economy Universal Cervical ... with synthtic white stockinette ... for flexion or extension. ... air dry. 3"H.,Universal size ...
... for use for lightweight padding. It can ... to line braces, prosthetics, orthotics and sports ... vibration and conforms to all body contours, ... is a 2mm thick gel sheet with ...
... patient need and comfort in mind, ... of products effectively address a variety ... frame attachment provides optimal post-operative support, ... superior support for patient maintenance and ...
Medicine Products: